Bioharvest Financial Statements From 2010 to 2026

CNVCFDelisted Stock  USD 5.13  0.07  1.35%   
Bioharvest Sciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Bioharvest Sciences' valuation are provided below:
Bioharvest Sciences does not presently have any fundamental signals for analysis.
Check Bioharvest Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bioharvest Sciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Bioharvest financial statements analysis is a perfect complement when working with Bioharvest Sciences Valuation or Volatility modules.
  
This module can also supplement various Bioharvest Sciences Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Bioharvest Sciences OTC Stock Operating Margin Analysis

Bioharvest Sciences' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Bioharvest Sciences Operating Margin

    
  (2.45) %  
Most of Bioharvest Sciences' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioharvest Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Bioharvest Sciences has an Operating Margin of -2.4469%. This is 93.02% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 55.59% lower than that of the firm.

Bioharvest Sciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bioharvest Sciences's current stock value. Our valuation model uses many indicators to compare Bioharvest Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioharvest Sciences competition to find correlations between indicators driving Bioharvest Sciences's intrinsic value. More Info.
Bioharvest Sciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioharvest Sciences' earnings, one of the primary drivers of an investment's value.

About Bioharvest Sciences Financial Statements

Bioharvest Sciences stakeholders use historical fundamental indicators, such as Bioharvest Sciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Bioharvest Sciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bioharvest Sciences' assets and liabilities are reflected in the revenues and expenses on Bioharvest Sciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bioharvest Sciences. Please read more on our technical analysis and fundamental analysis pages.
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product and medical cannabis. Canna-V-Cell Sciences is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
Note that the Bioharvest Sciences information on this page should be used as a complementary analysis to other Bioharvest Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Consideration for investing in Bioharvest OTC Stock

If you are still planning to invest in Bioharvest Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bioharvest Sciences' history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamental Analysis
View fundamental data based on most recent published financial statements
Transaction History
View history of all your transactions and understand their impact on performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum